Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001615774-18-012342
Filing Date
2018-11-09
Accepted
2018-11-09 07:31:32
Documents
52
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q s113742_10q.htm 10-Q 289183
2 EXHIBIT 31.01 s113742_ex31-01.htm EX-31.01 9604
3 EXHIBIT 31.02 s113742_ex31-02.htm EX-31.02 9606
4 EXHIBIT 32.01 s113742_ex32-01.htm EX-32.01 6361
  Complete submission text file 0001615774-18-012342.txt   2281774

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE tnxp-20180930.xml EX-101.INS 330026
6 XBRL SCHEMA FILE tnxp-20180930.xsd EX-101.SCH 30388
7 XBRL CALCULATION FILE tnxp-20180930_cal.xml EX-101.CAL 36852
8 XBRL DEFINITION FILE tnxp-20180930_def.xml EX-101.DEF 106279
9 XBRL LABEL FILE tnxp-20180930_lab.xml EX-101.LAB 252003
10 XBRL PRESENTATION FILE tnxp-20180930_pre.xml EX-101.PRE 189318
Mailing Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022
Business Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022 1-800-849-7894
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

EIN.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36019 | Film No.: 181171360
SIC: 2834 Pharmaceutical Preparations